Citrulline level is a potent indicator of acute rejection in the long term following pediatric intestinal/multivisceral transplantation

American Journal of Transplantation

Volumn 12, Issue SUPPL 4, 2012, Pages

  Hibi, T ^a,b   Nishida, S ^a,b   Garcia, J ^a,b   Tryphonopoulos, P ^a,b   Tekin, A ^a,b   Selvaggi, G ^a,b   Weppler, D ^a,b   Levi, D M ^a,b   Ruiz, P ^a,b   Tzakis, A G ^a,b  

^a UNIVERSITY OF MIAMI   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Acute cellular rejection; Citrulline; Intestinal transplantation; Multivisceral transplantation

Indexed keywords

BIOCHEMICAL MARKER; CITRULLINE; BIOLOGICAL MARKER;

ABDOMINAL INJURY; ACUTE GRAFT REJECTION; CHILD; CONFERENCE PAPER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; ENTEROPATHY; FEMALE; FOLLOW UP; GASTROSCHISIS; GRAFT RECIPIENT; HIRSCHSPRUNG DISEASE; HUMAN; HUMAN TISSUE; INTESTINE ATRESIA; INTESTINE BIOPSY; INTESTINE PSEUDOOBSTRUCTION; INTESTINE TRANSPLANTATION; INTESTINE TUMOR; INTESTINE VOLVULUS; MAJOR CLINICAL STUDY; MALE; MEGACYSTIS MICROCOLON; MICROVILLOUS INCLUSION DISEASE; MULTIVISCERAL TRANSPLANTATION; NECROTIZING ENTEROCOLITIS; NON INVASIVE MEASUREMENT; ORGAN TRANSPLANTATION; PEDIATRIC SURGERY; PREDICTIVE VALUE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; ARTICLE; BIOPSY; BLOOD; COHORT ANALYSIS; GRAFT REJECTION; INFANT; INTESTINE; LONGITUDINAL STUDY; METABOLISM; PATHOLOGY; RETROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; TRANSPLANTATION; VISCERA;

BIOLOGICAL MARKERS; BIOPSY; CHILD; CHILD, PRESCHOOL; CITRULLINE; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; INFANT; INTESTINES; LONGITUDINAL STUDIES; MALE; ORGAN TRANSPLANTATION; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; VISCERA;

EID: 84879511381     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2012.04155.x     Document Type: Conference Paper

References (37)

1. Selvaggi G, Gaynor JJ, Moon J, et al. Analysis of acute cellular rejection episodes in recipients of primary intestinal transplantation: A single center, 11-year experience. Am J Transplant 2007;7:1249-1257. (Pubitemid 46643107)
2. Fishbein TM. Intestinal transplantation. N Engl J Med 2009;361:998-1008.
3. Gondolesi G, Fishbein T, Chehade M, et al. Serum citrulline is a potential marker for rejection of intestinal allografts. Tranpslant Proc 2002;34:918-920. (Pubitemid 34556858)
4. Pappas PA, G Tzakis A, Gaynor JJ, et al. An analysis of the association between serum citrulline and acute rejection among 26 recipients of intestinal transplant. Am J Transplant 2004;4:1124-1132. (Pubitemid 38868604)
5. Gondolesi G, Ghirardo S, Raymond K, et al. The value of plasma citrulline to predict mucosal injury in intestinal allografts. Am J Transplant. 2006;6:2786-2790. (Pubitemid 44571701)
6. Ruiz P, Tryphonopoulos P, Island E, et al. Citrulline evaluation in bowel transplantation. Transplant Proc 2010;42:54-56.
7. David AI, Selvaggi G, Ruiz P, et al. Blood citrulline level is an exclusionary marker for significant acute rejection after intestinal transplantation. Transplantation 2007;84:1077-1081. (Pubitemid 350125347)
8. Crenn P, Coudray-Lucas C, Thuillier F, Cynober L, Messing B. Postabsorptive plasma citrulline concentration is a marker of absorptive enterocyte mass and intestinal failure in humans. Gastroenterology 2000;119:1496-1505. (Pubitemid 32198675)
9. Crenn P, Vahedi K, Lavergne-Slove A, Cynober L, Matuchansky C, Messing B. Plasma citrulline: A marker of enterocyte mass in villous atrophy-associated small bowel disease. Gastroenterology 2003;124:1210-1219. (Pubitemid 36531797)
10. Herbers AH, Feuth T, Donnelly JP, Blijlevens NM. Citrulline-based assessment score: First choice for measuring and monitoring intestinal failure after high-dose chemotherapy. Ann Oncol 2010;21:1706-1711.
11. Windmueller HG, Spaeth AE. Source and fate of circulating citrulline. Am J Physiol 1981;241:E473-E480.
12. Wakabayashi Y, Jones ME. Pyrroline-5-carboxylate synthesis from glutamate by rat intestinal mucosa. J Biol Chem 1983;258:3865-3872. (Pubitemid 13052878)
13. Wakabayashi Y, Yamada E, Hasegawa T, Yamada R. Enzymological evidence for the indispensability ofsmall intestine in the synthesis of arginine from glutamate: I. Pyrroline-5-carboxylate synthase. Arch Biochem Biophys 1991;291:1-8.
14. Rabier D, Kamoun P. Metabolism of citrulline in man. Amino Acids 1995;9:299-316. (Pubitemid 26018300)
15. Moinard C, Cynober L. Citrulline: A new player in the control of nitrogen homeostasis. J Nutr 2007;137(Suppl 2):1621S-1625S. (Pubitemid 46855521)
16. Mercer DF. Hot topics in postsmall bowel transplantation: Noninvasive graft monitoring including stool calprotectin and plasma citrulline. Curr Opin Organ. Transplant 2011;16:316-322.
17. Van Eijk HM, Dejong CH, Deutz NE, Soeters PB. Influence of storage conditions on normal plasma amino-acid concentrations. Clin Nutr 1994;13:374-380.
18. Pitkänen HT, Oja SS, Kemppainen K, Seppä JM, Mero AA. Serum amino acid concentrations in aging men and women. Amino Acids 2003;24:413-421. (Pubitemid 36745627)
19. Gondolesi GE, Kaufman SS, Sansaricq C, et al. Defining normal plasma citrulline in intestinal transplant recipients. Am J Transplant 2004;4:414-418. (Pubitemid 38282298)
20. Ruiz P, Bagni A, Brown R, et al. Histological criteria for the identification of acute cellular rejection in human small bowel allografts: Results of the pathology workshop at the VIII International Small Bowel Transplant Symposium. Transplant Proc 2004;36:335-337. (Pubitemid 38407186)
21. Schwartz GJ, Muñoz A, Schneider MF, et al. New equations to estimate GFR in children with CKD. J Am Soc Nephrol 2009;20:629-637.
22. Quintini C, Kato T, Gaynor JJ, et al. Analysis of risk factors for the development of posttransplant lymphoprolipherative disorder among 119 children who received primary intestinal transplants at a single center. Transplant Proc 2006;38:1755-1758. (Pubitemid 44190042)
23. Przepiorka D, Weisdorf D, Martin P, et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995;15:825-828.
24. Parizhskaya M, Redondo C, Demetris A, et al. Chronic rejection of small bowel grafts: Pediatric and adult study of risk factors and morphologic progression. Pediatr Dev Pathol 2003;6:240-250. (Pubitemid 36676961)
25. Takahashi H, Kato T, Delacruz V, et al. Analysis of acute and chronic rejection in multiple organ allografts from retransplantation and autopsy cases of multivisceral transplantation. Transplantation 2008;85:1610-1616.
26. Jaeschke R, Guyatt GH, Sackett DL. Users' guides to the medical literature: III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group. JAMA 1994;271:703-707. (Pubitemid 24061707)
27. Mazariegos GV, Steffick DE, Horslen S, et al. Intestine transplantation in the United States, 1999-2008. Am J Transplant 2010;10(4 Pt 2):1020-1034.
28. Andreev VP, Tryphonopoulos P, Blomberg BB, et al. Peripheral blood gene expression analysis in intestinal transplantation: A feasibility study for detecting novel candidate biomarkers of graft rejection. Transplantation 2011;92:1385-1391.
29. Tsai HL, Island ER, Chang JW, et al. Association between donorspecific antibodies and acute rejection and resolution in small bowel and multivisceral transplantation. Transplantation 2011;92:709-715.
30. Ashokkumar C, Talukdar A, Sun Q, et al. Allospecific CD154+ T cells associate with rejection risk after pediatric liver transplantation. Am J Transplant 2009;9:179-191.
31. Ashokkumar C, Gupta A, Sun Q, et al. Allospecific CD154+ T cells identify rejection-prone recipients after pediatric small-bowel transplantation. Surgery 2009;146:166-173.
32. Sudan D, Vargas L, Sun Y, Bok L, Dijkstra G, Langnas A. Calprotectin: A novel noninvasive marker for intestinal allograft monitoring. Ann Surg 2007;246:311-315. (Pubitemid 47196530)
33. Akpinar E, Vargas J, Kato T, et al. Fecal calprotectin level measurements in small bowel allograft monitoring: A pilot study. Transplantation 2008;85:1281-1286. (Pubitemid 351670477)
34. Fishbein T, Novitskiy G, Mishra L, et al. NOD2-expressing bone marrow-derived cells appear to regulate epithelial innate immunity of the transplanted human small intestine. Gut 2008;57:323-330. (Pubitemid 351288097)
35. Olde Damink SW, Jalan R, Redhead DN, Hayes PC, Deutz NE, Soeters PB. Interorgan ammonia and amino acid metabolism in metabolically stable patients with cirrhosis and a TIPSS. Hepatology 2002;36:1163-1171. (Pubitemid 35253432)
36. Tuchman M. Persistent acitrullinemia after liver transplantation for carbamylphosphate synthetase deficiency. N Engl J Med 1989;320:1498-1499. (Pubitemid 19143725)
37. van de Poll MC, Ligthart-Melis GC, Boelens PG, Deutz NE, van Leeuwen PA, Dejong CH. Intestinal and hepatic metabolism of glutamine and citrulline in humans. J Physiol 2007;581(Pt 2):819-827. (Pubitemid 46831774)